http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0709709-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d0f1ef1aa86daba21657283ec32f529 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 |
filingDate | 2007-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40e320026fd54d3fb03e5fce387ff870 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f7a611bedad8391d14705d35bd43002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a30cf8f38aa50f9f6165d4eb40f5bf1a |
publicationDate | 2011-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-PI0709709-A2 |
titleOfInvention | compound, pharmaceutical composition, method of treating cell B cancer or malignancies, use of a compound, and process for preparing a compound |
abstract | <B> COMPOUND, PHARMACEUTICAL COMPOSITION, CANCER TREATMENT METHOD OR B-CELL MALIGNITIES, USE OF A COMPOUND, AND, PROCESS FOR PREPARING A COMPOUND <D> The present invention relates to borrelidine derivatives that are useful in medicine, eg in the treatment of B cell cancer or malignancies, or other diseases in which angiogenesis contributes to the pathology including ophthalmic disorders such as diabetic retinopathy as well as age-related macular degeneration (AMD), corneal neovascularization and retinopathy or prematurity. The present invention also provides methods for the production of these compounds and their use in medicine, in particular in the treatment and prophylaxis of cancer or B-cell malignancies and other diseases in which angiogenesis is involved in the pathogenic process. |
priorityDate | 2006-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 995.